Form 4 for RGNX REGENXBIO Inc.
Accepted 2024-08-05 00:00:00 ET · period of report 2024-08-01 · accession 0001562180-24-006015 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DMT | 2024-08-05 | 2024-08-01 | RGNX | KARABELAS ARGERIS N | Dir | S - Sale+OE | $13.51 | -10.1K | 11.3K | -47% | -$136.5K |
| DMT | 2024-08-05 | 2024-08-01 | RGNX | KARABELAS ARGERIS N | Dir | M - OptEx | $3.85 | +10.1K | 21.3K | +90% | +$38.9K |
| DMT | 2024-08-05 | 2024-08-01 | RGNX | KARABELAS ARGERIS N | Dir | M - OptEx | $0.00 | -10.1K | 1,400 | -88% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-08-01 | S | D | 400 | $14.59 | 11,386 | D | — | — | (F3) This transaction was executed in multiple trades at prices ranging from $14.44 to $14.65. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| 2 | Common | Common Stock | 2024-08-01 | S | D | 9,600 | $13.45 | 11,786 | D | — | — | (F2) This transaction was executed in multiple trades at prices ranging from $13.20 to $14.05. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| 3 | Common | Common Stock | 2024-08-01 | M | A | 100 | $12.74 | 21,386 | D | — | — | |
| 4 | Common | Common Stock | 2024-08-01 | M | A | 10,000 | $3.76 | 21,286 | D | — | — | |
| 5 | Common | Common Stock | 2024-08-01 | S | D | 100 | $15.00 | 11,286 | D | — | — | |
| 6 | Derivative | Stock Options (Right to Buy) | 2024-08-01 | M | D | 10,000 | $0.00 | 20,000 | D | $3.76 · — to 2025-05-19 | 10,000 Common Stock | (F5) The previously granted option, representing a right to purchase a total of 40,000 shares, became exercisable as follows: 25% of the shares subject to the option vested on May 19, 2015, and the balance vested equal installments over the next 24 months. |
| 7 | Derivative | Stock Options (Right to Buy) | 2024-08-01 | M | D | 100 | $0.00 | 1,400 | D | $12.74 · — to 2026-06-01 | 100 Common Stock | (F4) The previously granted option, representing a right to purchase a total of 12,500 shares, became exercisable as follows: the option vested in 12 equal monthly installments following June 1, 2016. |